Clinical Trial Update: A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade [Phase 2]

View source ↗

Summary

Phase 2 safety, tolerability, PK, and efficacy study of CS-1103 following fentanyl challenge with naloxone blockade; status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fentanyl Overdose
• Fentanyl Poisoning

Drugs mentioned

• CS-1103

Snippet

Sponsor: Clear Scientific, Inc. | Conditions: Fentanyl Overdose, Fentanyl Poisoning | Phase 2 | Status: NOT_YET_RECRUITING